Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model

Journal of Ethnopharmacology

Volumn 146, Issue 1, 2013, Pages 300-310

  De Almeida, Ana Beatriz Albino ^a   Sánchez Hidalgo, Marina ^b   Martín, Antonio Ramón ^b   Luiz Ferreira, Anderson ^a,c   Trigo, José Roberto ^a   Vilegas, Wagner ^d   Dos Santos, Lourdes Campaner ^d   Souza Brito, Alba Regina Monteiro ^a   De La Lastra, Catalina Alarcón ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SEVILLE   (Spain)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Arctium lappa; Colitis; COX 2; Onopordopicrin; Rats; TNBS

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LACTONE DERIVATIVE; MYELOPEROXIDASE; ONOPORDOPICRIN; SESQUITERPENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARCTIUM LAPPA; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MUCUS SECRETION; NONHUMAN; RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARCTIUM; COLITIS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; MALE; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

ARCTIUM LAPPA; ASTERACEAE; RATTUS;

EID: 84874113938     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.12.048     Document Type: Article

References (38)

1. S.N. Agoff, T.A. Brentnall, D.A. Crispin, S.L. Taylor, S. Raaka, R.C. Haggitt, M.W. Reed, and I.A. Afonina The role of cyclo-oxygenase 2 in ulcerative colitis-associated neoplasia American Journal of Pathology 157 2000 737 745
2. C. Bobin-Dubigeon, X. Collin, N. Grimaud, J.M. Robert, G. Le Baut, and J.Y. Petit Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis European Journal of Pharmacology 431 2001 103 110
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 1976 248 254
4. J.B. Calixto, M.M. Campos, M.F. Otuki, and A.R. Santos Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules Planta Medica 70 2004 93 103
5. M.K. Cho, Y.P. Jang, Y.C. Kim, and S.G. Kim Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent KK inhibition: the role in TNF-alpha inhibition International Immunopharmacology 4 2004 1419 1429
6. M.S. da Silva, S. Sánchez-Fidalgo, E. Talero, A. Cárdeno, M.A. da Silva, W. Villegas, A.R. Souza Brito, and C.A. de La Lastra Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby and Grimes in TNBS colitis model Journal of Ethnopharmacology 128 2010 467 475
7. A.B. de Almeida, A. Luiz-Ferreira, M. Cola, L.D. Magri, L.M. Batista, J.A. Paiva, J.R. Trigo, and A.R. Souza-Brito Anti-ulcerogenic mechanisms of the sesquiterpene lactone onopordopicrin-enriched fraction from Arctium lappa L. (Asteraceae): role of somatostatin, gastrin, and endogenous sulfhydryls and nitric oxide Journal of Medicinal Food 15 2012 378 383
8. A.B.A. de Almeida, A. Luiz-Ferreira, M. Cola, L.M. Batista, L. Di Pietro Magri, M.R.F. Tiene, L.C. Santos, W. Vilegas, and A.R.M. Souza-Brito Antiulcerogenic activity of aqueous fraction from leaves of Arctium lappa L. (Asteraceae) Journal of Medicinal Plants Research 6 2012 1764 1769
9. F.M. De-Faria, A. Luiz-Ferreira, E.A. Socca, A.C. de Almeida, R.J. Dunder, L.P. Manzo, M.A. da Silva, W. Vilegas, A.L. Rozza, C.H. Pellizzon, L.C. Dos Santos, and A.R. Souza Brito Effects of Rhizophora mangle on experimental colitis induced by TNBS in rats Evidence Based Complementary and Alternative Medicine 2012 753971
10. R.C. Dutra, R.F. Claudino, A.F. Bento, R. Marcon, E.C. Schmidt, Z.L. Bouzon, L.F. Pianowski, and J.B. Calixto Preventive and therapeutic euphol treatment attenuates experimental colitis in mice PLoS One 6 2011 e27122
11. F.C. Ferrari, L.C. Ferreira, M.R. Souza, A. Grabe-Guimarães, C.A. Paula, S.A. Rezende, and D.A. Saúde-Guimarães Anti-Inflammatory sesquiterpene lactones from Lychnophora trichocarpha Spreng. (Brazilian Arnica) Phytotherapy Research 2012 (Epub ahead of print)
12. L.C. Fonseca, S.S. Dadarkar, A.S. Lobo, A.C. Suthar, V.S. Chauhan, S. Chandrababu, S.D. Sharma, N.M. Dagia, and M. Padigaru 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation European Journal of Pharmacology 644 2010 220 229
13. A.C. Ford, W.J. Sandborn, K.J. Khan, S.B. Hanauer, N.J. Talley, and P. Moayyedi Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis American Journal of Gastroenterology 106 2011 644 659
14. M.B. Grisham, R.D. Specian, and T.E. Zimmerman Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis Journal of Pharmacology and Experimental Therapeutics 271 1994 1114 1121
15. 2+ influx on TNF{alpha}-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts American Journal of Physiology Gastrointestinal and Liver Physiology 301 2011 G356 G367
16. T.C. Huang, S.S. Tsai, L.F. Liu, Y.L. Liu, H.J. Liu, and K.P. Chuang Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model World Journal of Gastroenterology 33 2010 4193 4199
17. A.F. Kavanaugh, L.F. Mayer, J.J. Cush, and S.B. Hanauer Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease American Journal of Medicine 124 2011 e1 18
18. Y.S. Kim, and S.B. Ho Intestinal goblet cells and mucins in health and disease: recent insights and progress Current Gastroenterology Reports 12 2010 319 330
19. T.W. Lee, and R.N. Fedorak Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology Gastroenterology clinics of North America 39 2010 543 557
20. C. Lima de Albuquerque, M. Comalada, D. Camuesco, M.E. Rodríguez-Cabezas, A. Luiz-Ferreira, A. Nieto, A.R.M. Souza Brito, A. Zarzuelo, and J. Gálvez Effect of kale and papaya supplementation in colitis induced by trinitrobenzenesulfonic acid in the rat European e-Journal of Clinical Nutrition and Metabolism 5 2010 e111 e116
21. F. Magro, and F. Portela Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies BioDrugs 24 2010 l3 14
22. T. Malik, and P. Mannon Inflammatory bowel diseases: emerging therapies and promising molecular targets Frontiers in Bioscience 4 2012 1172 1189
23. I. Masoodi, B.M. Tijjani, H. Wani, N.S. Hassan, A.B. Khan, and S. Hussain Biomarkers in the management of ulcerative colitis: a brief review German Medical Science 9 2011 1 7
24. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
25. F.S. Predes, A.L. Ruiz, J.E. Carvalho, M.A. Foglio, and H. Dolder Antioxidative and in vitro antiproliferative activity of Arctium lappa root extracts BMC Complementary and Alternative Medicine 11 2011 1 5
26. T. Qidwai, and F. Khan Tumour necrosis factor gene polymorphism and disease prevalence Scandinavian Journal of Immunology 74 2011 522 547
27. M.T. Rizzo Cyclooxygenase-2 in oncogenesis Clinica Chimica Acta 412 2011 671 687
28. M. Sánchez-Hidalgo, A.R. Martín, I. Villegas, and C. Alarcón De La Lastra Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats Biochemical Pharmacology 69 2005 1733 1744
29. U.P. Singh, N.P. Singh, B. Busbee, H. Guan, B. Singh, R.L. Price, D.D. Taub, M.K. Mishra, M. Nagarkatti, and P.S. Nagarkatti Alternative medicines as emerging therapies for inflammatory bowel diseases International Reviews of Immunology 31 2012 66 84
30. E.H. Soh, S.A. Jang, H. Joo, S. Park, S.C. Kang, C.H. Lee, and S.Y. Kim Anti-allergic and anti-inflammatory effects of butanol extract from Arctium Lappa L Clinical and Molecular Allergy 9 2011 1 11
31. A.A. te Velde, M.I. Verstege, and D.W. Hommes Critical appraisal of the current practice in murine TNBS-induced colitis Inflammatory Bowel Disease 12 2006 995 999
32. W.J. Tsai, C.T. Chang, G.J. Wang, T.H. Lee, S.F. Chang, S.C. Lu, and Y.C. Kuo Arctigenin from Arctium lappa inhibits interleukin-2 and interferon gene expression in primary human T lymphocytes Chinese Medicine 6 2011 1 8
33. S.K. Wasan, and S.V. Kane Adalimumab for the treatment of inflammatory bowel disease Expert Review of Gastroenterology and Hepatology 5 2011 679 684
34. K.K. Wu Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators Prostaglandins, Leukotrienes, and Essential Fatty Acids 72 2005 89 93
35. B. Yin, X. Hu, J. Wang, H. Liang, X. Li, N. Niu, B. Li, X. Jiang, and Z. Li Blocking TNF-α by combination of TNF-α- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-induced colitis in rats European Journal of Pharmacology 656 2011 119 124
36. F. Zhao, L. Wang, and K. Liu In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway Journal of Ethnopharmacology 122 2009 457 462
37. Z.J. Zhao, J.Y. Xiang, L. Liu, X.L. Huang, and H.T. Gan Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice International Immunopharmacology 12 2012 169 174
38. M. Zwolinska-Wcislo, T. Brzozowski, A. Ptak-Belowska, A. Targosz, K. Urbanczyk, S. Kwiecien, and Z. Sliwowski Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis World Journal of Gastroenterology 17 2011 4076 4089